NIH-funded research NIH-funded research

Neuromodulation clues in late-life depression and its impact on mood, thinking, and daily function

Official title: Neuromodulatory system abnormalities in late life depression: Associations with mood, cognition, and motor frailty

Funded at University of California, San Francisco · NIH-11357619 · Data updated 2026-11-12

This study looks at how brain chemical systems linked to mood and movement lie behind late-life depression and its effects on thinking and frailty in older adults.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startJuly 1, 2025
Project endApril 30, 2030
Funding year2026
Award (this year)$3,131,019
NIH project number4RF1MH139950-02
Project IDNIH-11357619 on NIH RePORTER

Who could benefit from this research

Could help

Older adults with Major Depressive Disorder or late-life depression, and individuals at risk for cognitive decline.

Less likely to help

Individuals without depression or neuromodulatory-related risks may not directly benefit from this study.

What this research studies

Researchers at UCSF will examine how changes in brainstem and basal forebrain networks related to mood and alertness contribute to depression, slower thinking, and physical frailty in older adults. The project uses imaging and clinical assessments to map neuromodulatory system abnormalities and their connections to mood, cognition, and motor function. By understanding these links, the team aims to identify early markers that predict risk of cognitive decline and functional loss in late-life depression. Participants may include older adults with or without depression, followed over time to observe how neuromodulatory changes relate to outcomes. The ultimate goal is to inform earlier interventions to improve mood, cognitive health, and daily functioning.

Why it matters

Potential benefit: Could lead to earlier detection of people at risk for cognitive decline and frailty, enabling timely interventions to improve mood and functioning.

How similar studies have gone: Previous research links neuromodulatory system changes to mood and cognitive outcomes, supporting potential relevance of this approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Mackin, Robert Scott — University of California, San Francisco
  • Study coordinator: Mackin, Robert Scott

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.